NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

At the next ASM (presumably post-approval) NWBO should lay out a fairly detailed plan for how they are going to use the UK market to become profitable, including medical tourism. They can do this and after so many years of virtual silence and ambiguity when they do speak, they should do this. Will they be forthright at the ASM about the numbers and how they are going to start making money after all these years? As always: Who knows?

In theory, the extra months spent wordsmithing the presentation to MHRA should deduct drastically from the time needed to prepare the application to the FDA. There is the real risk that in practice NWBO probably find at least one way to make it more complicated because ‘everything takes longer.’ NWBO should also address this elephant in the room in a clear way.